Clinical use of pasireotide for Cushing's disease in adults
Filippo Ceccato, Carla Scaroni, Marco Boscaro Endocrinology Unit, Department of Medicine, Padova University Hospital, Padova, Italy Cushing’s disease: Excessive corticotroph hormone levels sustained by an adrenocorticotropic hormone-secreting pituitary adenoma lead to a severe clinical con...
Saved in:
Main Authors: | Ceccato F (Author), Scaroni C (Author), Boscaro M (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2015-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pasireotide: a novel treatment for patients with acromegaly
by: Cuevas-Ramos D, et al.
Published: (2016) -
Determinants of Clinical Behavior and Prognosis in Cushing's Disease: A Quest for Useful Biomarkers
by: Laura C. Hernández-Ramírez
Published: (2022) -
Cushing disease in pediatrics: an update
by: Marcio José Concepción-Zavaleta, et al.
Published: (2023) -
CLINICAL EXAMPLE OF ITSENKO-CUSHING DRUG SYNDROME
by: N.A. INOYATOVA, et al.
Published: (2019) -
Successful Control of Hypoglycemia with Pasireotide LAR in a Patient with Inappropriate Insulin Secretion
by: Rouland A, et al.
Published: (2021)